Abstract
(Cell Reports 15, 1024–1036; May 3, 2016) In the originally published version of this article, the concentration of dual-SMAD inhibitors used was incorrectly reported in the Supplemental Experimental Procedures as “0.1 mM LDN193189 (Stemgent) and 10 mM SB431542 (Tocris)” instead of “0.1 μM LDN193189 (Stemgent) and 10 μM SB431542 (Tocris).” The Supplemental Experimental Procedures section has now been corrected online. The authors regret this error.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2525 |
| Number of pages | 1 |
| Journal | Cell reports |
| Volume | 20 |
| Issue number | 10 |
| DOIs |
|
| State | Published - Sep 5 2017 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017 The Author(s)
Fingerprint
Dive into the research topics of 'Erratum: Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells (Cell Reports (2016) 15(5) (1024–1036) (S2211124716303965) (10.1016/j.celrep.2016.03.090))'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS